A family with three germline mutations in BRCA1 and BRCA2

Clinical Genetics

Volumn 54, Issue 3, 1998, Pages 215-218

  Liede, Alexander ^a,b   Metcalfe, Kelly ^a   Offit, Kenneth ^c   Brown, Karen ^d   Miller, Shari ^e   Narod, Steven A ^a   Moslehi, Roxana ^a,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b CANCER CARE ONTARIO   (Canada)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e Bethesda Memorial Hospital Florida   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Ashkenazi Jewish; BRCA1; BRCA2; Breast cancer; Cancer genetics; Genetic counselling; Hereditary cancer; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GENETICS; CLINICAL ARTICLE; FAMILY STUDY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GERM LINE; HUMAN; JEW; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0031712163     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1998.tb04287.x     Document Type: Article

References (14)

1. Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 1995: 11: 198-200.
2. Roa BB, Boyd AA, Vocik K, Richards CS. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 1996: 14: 185-187.
3. Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 1996: 14: 188-190.
4. Helmrich SP, Shapiro S, Rosenberg L, Kaufman DW, Sloan D, Bain C. Risk factors for breast cancer. Am J Epidemiol 1983: 117: 35-45.
5. Fitzgerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S et al. Germ-line mutations in Jewish and non-Jewish women with early-onset breast cancer. New Engl J Med 1996: 334: 143-149.
6. Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J et al. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Human Genet 1997: 60: 505-514.
7. Robson ME, Offit K. New BRCA2 mutation in an Ashkenazi Jewish family with breast and ovarian cancer. Lancet 1997: 350: 117-118.
8. Ramus SJ, Friedman LS, Gayther SA, Ponder BAJ. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2. Nat Genet 1997: 15: 14-15.
9. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New Engl J Med 1997: 336: 1401-1408.
10. Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M et al. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast ovarian cancer families. Am J Human Genet 1997: 60: 1059-1067.
11. Stoppa-Lyonnet D, Fricker JP, Essioux L, Pages S, Limacher JM, Sobol H, Laurent-Puig P et al. Segregation of two BRCA1 mutations in a single family. Am J Human Genet 1996: 59: 479-481.
12. Liede A, Rehal P, Vesprini D, Jack E, Abrahamson J, Narod SA. A breast cancer patient of Scottish descent with germ-line mutations in BRCA1 and BRCA2. Am J Human Genet 1998: 62: 1543-1544.
13. Vogel F, Motulsky AG. Human Genetics: Problems and Approaches. New York: Springer, 1997.
14. Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK et al. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 1996: 2: 1179-1183.